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A simple procedure to isolate neural stem cells would greatly facilitate direct studies of their properties. Here, we exploited the increase in
EGF receptor (EGFR) levels, that occurs in late development stem cells or in younger precursors upon exposure to FGF-2, to isolate cells
expressing high levels of EGFR (EGFRhigh) from the developing and the adult brain. Independently of age and region of isolation, EGFRhigh
cells were highly enriched in multipotent precursors and displayed similar antigenic characteristics, with the exception of GFAP and Lex/
SSEA-1 that were mainly expressed in adult EGFRhigh cells. EGFR levels did not correlate with neurogenic potential, indicating that the
increase in EGFR expression does not directly affect differentiation. Instead, in the brain, many EGFRhigh precursors showed tangential
orientation and, whether isolated from the cortex or striatum, EGFRhigh precursors displayed characteristics of cells originating from the
ventral GZ such as expression Dlx and Mash-1 and the ability to generate GABAergic neurons and oligodendrocytes. Moreover, migration of
EGFRhigh cells on telencephalic slices required EGFR activity. Thus, the developmentally regulated increase in EGFR levels may affect
tangential migration of multipotent precursors. In addition, it can be used as a marker to effectively isolate telencephalic multipotent
precursors from embryonic and adult tissue.
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Neural stem cells (NSCs) are able to generate more stem
cells (self-renewing) and to give rise to the main cell types of
the mammalian central nervous system (CNS) (multipotent).
Several precursor types with characteristics of NSCs have
been isolated from different regions of the embryonic and
adult brain and the relationship among these cell types is not
clear (Morshead and van der Kooy, 2001; Temple, 2001). For
example, in the SVZ, a subset of cells expressing GFAP
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E-mail address: f.ciccolini@uni-hd.de (F. Ciccolini).itory neurons by giving rise to a population of rapidly
dividing neurogenic precursors, termed type C cells (Capela
and Temple, 2002; Doetsch et al., 1999b). NSCs are also
present in the hippocampus, although their identity is still
unclear (Seaberg and van der Kooy, 2002). Finally, a
population of glial progenitors displaying NSC properties
has been found in the adult brain parenchyma (Kondo and
Raff, 2000; Nunes et al., 2003; Palmer et al., 1999). These
progenitors display antigens of the early glial lineage, such as
the gangliosides recognised by A2B5 monoclonal antibody,
and multipotency upon in vitro culturing. In contrast, early
development NSCs do not express neural markers such as
A2B5, E-NCAM, and GFAP (Cai et al., 2002; Maric et al.,
2003). However, at mid–late development, at least a fraction
of NSCs may display antigens found in radial glia cells84 (2005) 112 – 125
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precursors with characteristic of stem cells have not been
isolated from the embryonic brain. In the absence of specific
markers, NSCs have been identified in culture by their ability
to proliferate in response to EGF or FGF-2. These studies
have shown that early development precursors respond to
FGF-2 only, whereas later in development, they acquire
additionally the ability to respond to EGF and upregulate
EGFR levels (Ciccolini, 2001; Ciccolini and Svendsen, 1998;
Tropepe et al., 1999). The biological significance of this
event is not clear and acquisition of EGF responsiveness has
been involved in the regulation of several aspects of neural
precursor development such as differentiation potential,
cycling ability, and migration. To investigate this issue and
achieve a better integration between embryonic and adult
precursors, we have developed a FACS-based stem cell
isolation procedure to isolate EGFRhigh cells from different
regions of the developing telencephalon. This approach
allowed us to effectively purify precursors with NSC
characteristics and directly study their properties. Our data
indicate that EGFRhigh cells represent a population of
migrating multipotent precursors and that developmentally
regulated increase in EGFR levels participates in the
regulation of their migration.Experimental procedures
Tissue dissection
Embryonic tissue
Time-mated pregnant (plug day = 1) CD1 albino mice
(Charles River) were killed by increasing CO2 concen-
tration followed by neck dislocation. Brain dissection was
done in PBS containing 0.6% glucose. Embryonic striata
were dissected to maximise the excision of the GZ as
described before (Ciccolini and Svendsen, 2001), while for
the cortex, a piece of the whole cortical anlage was
dissected. Mechanically dissociated tissue was transferred
into ice-cold culture medium consisting of NS-A basal
serum-free media (Euroclone), 2 mM l-glutamine, 0.6%
glucose (Sigma), and 2% B27% (GIBCO). Dissociated
cells were plated in culture flasks (Nunc) at a density of
105 cells/ml in culture medium containing 10 ng/ml FGF-2
(R&D System).
Adult tissue
Adult (2 to 4 months old) CD1 mice were decapitated
and whole brains were removed. Periventral and cortical
regions of the forebrain were dissected in PBS containing
0.6% glucose. Tissue was finely minced and incubated in
PBS containing papain (2.5 U/ml), DNase (250 U/ml),
cystein (0.18 mg/ml), and EDTA (0.18 mg/ml). After 15
min at 37-C, the papain/DNase solution was removed and
enzymatic digestion was stopped by washing the tissue in
NSA medium containing 0.7 mg/ml ovomucoid (all fromSIGMA). Dissociated cells were plated in culture medium
as described before. In some experiments, adult tissue
dissociation was done without enzymatic digestion. Instead,
tissue was incubated in PBS containing 0.6% glucose at
37-C for 5 min and dissociated by mechanical trituration.
Neurosphere cultures
After sorting, different cell numbers were plated by
FACS-automated cell deposition in 96- or 6-well plates
(Nunc) in 50 Al (96-well plates) or 2 ml (6-well plates) of
culture medium supplemented with EGF (20 ng/ml) and
FGF-2 (10 ng/ml) as indicated. For each sorted population,
the following numbers of cells were plated: EGF-A+/PI, 1
cell/well; EGF-A/PI, PI 10 cells/well; A2B5+/ PI,
A2B5/PI, 2000 cells. Neurosphere formation was scored
after 10 days. The ability to generate secondary neuro-
spheres was determined by mechanical dissociation of
primary neurospheres and replating of the single cell sus-
pension in EGF and FGF-2 culture medium. Long-term
neurosphere cultures were passaged every 7 days. At each
passage, cells were dissociated and replated at a density of
50,000–100,000 cells/ml. For differentiation, neurospheres
were transferred to poly-l-lysine (PLL)-coated chamber
slides (Nunclon) in EGF and FGF-2 culture medium. After
7 days, the medium was replaced with culture medium
containing 1% FCS and 2 ng/ml FGF-2. After 7 days in
these conditions, cells were fixed and processed for immu-
nocytochemistry to assess their phenotype.
FACS analysis
Labelling with EGF conjugated to Alexa 488 (EGF-A)
Cells were labelled immediately after dissection or after
being plated at a density of 105 cells/ml in FGF-2 culture
medium, for 24 or 48 h. Mechanically dissociated cells were
resuspended in ice-cold sorting medium: NSA/Leibovitz
medium (GIBCO) (1:1), 2% B27, 1% foetal calf serum
(FCS), 1 Ag/ml propidium iodide (PI) (Sigma), and/or
without 20 ng/ml EGF-A (Molecular Probes). Sorting was
performed on a Vantage flow cytometer (Becton-Dickinson)
at 1000–3000 cells/s. FACS gates were set using cells
stained with PI only and cells that had been incubated with
20 ng/ml EGF (Sigma) for 10 min at 37-C prior to being
resuspended in sorting medium containing EGF Alexa 488
(control). EGF-A and EGF-A+ populations were gated on
the basis of a 20-fold decrease or increase in fluorescence
levels with respect to the more fluorescent control cells. To
decrease variability among experiments, it was critical to
reduce as much as possible the time between dissection and
sorting and to avoid fluctuation of CO2 concentration during
the first week in culture.
Live immunostaining with LB1, A2B5, and O4 antibodies
Cells were incubated with primary and secondary anti-
bodies (conjugated to Alexa 488, Molecular Probes) in
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using cells stained with PI and secondary antibodies.
Organotypic slice cultures
Embryos were removed by caesarean section and placed
in ice-cold Krebs’ buffer pH 7.4 and containing (mM) 126
NaCl, 2.5 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.5 CaCl2, 25
NaHCO3, and 11 glucose. Brains were dissected and
embedded in 4% low melting point agarose (SIGMA).
Two-hundred-Am-thick coronal vibrotome sections were
placed in Krebs’ buffer. After 15 min, sections were
transferred onto polycarbonate culture membranes (pore
size 0.4 Am; Millipore) in culture medium in the presence or
absence of 20 ng/ml EGF and 5 Ag/ml PD 158780 (EGFR
inhibitor, Calbiochem). After 1 to 2 h at 37-C and 5% CO2,
cellular aggregates were positioned onto the slices and
returned to the incubator. Before analysis by fluorescence
microscopy, slices were fixed in 3% paraformaldehyde in
PBS containing 4% sucrose for 20 min, rinsed in PBS, and
mounted on glass coverslips in mounting medium (Vector).
Cell aggregates were prepared from EGF-A+- and EGF-
A-sorted E18 striatal cells. After labelling with DiI (see
below), cells were rinsed with culture medium supple-
mented with 1% FCS. After centrifugation, cell pellets were
left in centrifuge tubes at 37-C. After 30 min, aggregates
were gently dislodged and applied to the slices with a
micropipette.
DiI labelling
The fluorescent dye DiI (Molecular Probes) was resus-
pended in ethanol according to the manufacturer’s instruc-
tions and added to culture medium at a dilution of 1:1000.
After DiI addition, cells were returned to the incubator for 2
min and then washed with culture medium supplemented
with 1% FCS.
Antibodies
The following antibodies were used at the indicated
dilution: mouse monoclonal antibody to beta tubulin type III
(TuJ1), 1:400 (SIGMA); rabbit polyclonal antibody to glial
fibrillary acidic protein (GFAP), 1:1000 (Dako); mouse
monoclonal antibody to RC2, 1:100; mouse monoclonal
antibody to Lex/SEEA-1, 1:100 (Developmental Studies
Hybridoma Bank); mouse monoclonal antibody to nestin,
1:100 (Pharmingen); mouse monoclonal antibody to O4,
1:200 (UBI); mouse monoclonal antibody to the ganglioside
GD3 LB1, 1:10; mouse monoclonal antibody to A2B5,
1:10; rat monoclonal antibody to AN2, 1:10 (a gift of Dr. J.
Trotter, University of Mainz, Mainz, Germany); rabbit
polyclonal antibody to Dlx, 1:400 (a gift from Dr. G.
Panganiban, University of Wisconsin, Madison, USA);
rabbit polyclonal antibody to Dlx-2, 1:2000 (Chemicon);
mouse monoclonal antibody to Mash-1, 1:2 (a gift from Dr.D. Andersen, Howard Hughes Medical Institute, Pasadena,
USA); sheep polyclonal antibody to EGFR 1:100, 1:500
(Biodesign International); rabbit polyclonal antibody to
BLBP, 1:200 (a gift from Dr. N. Heintz, Howard Hughes
Medical Institute, Rockefeller University, New York, USA);
rabbit polyclonal antibody to gamma amino butyric acid
(GABA), 1:500 (SIGMA); mouse monoclonal antibody to
alpha-tubulin, 1:50,000 (SIGMA-ALDRICH); rabbit poly-
clonal to Ki67, 1:500 (Chemicon).
Western blot
After dissection, E18 striatal cells were stained with
EGF-A and sorted by FACS as described above. Sorted cells
were collected by centrifugation and counted. Similar cell
numbers were resuspended in PBS and mixed 1:1 with
sample buffer containing 4% SDS, 20% glycerol, 10% 2-
mercaptoethanol, 0.004% bromophenol blue, and 0.125 M
Tris–HCl pH 6.8 (all from SIGMA). The mixtures were
incubated at 95-C for 5 min and then loaded onto 7.5%
polyacrylamide minigel (Protogel). After electrophoresis,
proteins were transferred onto Hybond ECL nitrocellulose
membrane (Amersham). Membranes were then blocked in
5% dry milk and 0.2% Tween 20 in PBS (PBST) for 1 h.
After blocking, membranes were incubated for 1 h at room
temperature with primary EGFR and tubulin antibodies
diluted in PBST. Incubation with secondary peroxidase-
conjugated donkey anti-sheep or goat anti-mouse antibodies
(SIGMA, dilution 1:10,000 and 1: 50,000, respectively) was
also conducted for 1 h at room temperature. The labelled
bands were visualised by chemiluminescence using ECL
detection kit (Amersham).
Immunocytochemistry
Double immunostaining on differentiated neurosphere
was done using monoclonal antibody to (TuJ1) in combi-
nation with either polyclonal antibody to GFAP or mono-
clonal antibody to O4. For TuJ1 and GFAP immunostaining,
cells were fixed in 3% paraformaldehyde in PBS containing
4% sucrose for 10 min, rinsed several times in glycine (10
mM in PBS), permeabilised in NP40 (0.5% in PBS) for 5
min, and blocked in goat serum (1.5% in PBS) for 30 min,
all done at room temperature. Next, cells were incubated
with primary antibodies overnight at 4-C. For O4, A2B5,
LB1, AN2, and Lex-SSEA-1, staining cells were incubated
with the primary antibodies for 30 min at 4-C prior to being
fixed and processed for immunostaining as described above.
Acutely dissociated E14 and E18 cells or sorted EGF-A+
cells were isolated as described above and plated onto PLL-
coated chamber slides in culture medium supplemented with
B27 in the absence of exogenous EGF and FGF-2. Cells
were returned to the incubator and left to attach to the
substrate and after 1 h fixed and processed for immuno-
chemistry as described above. Primary antibody binding
was detected using Alexa 488 and biotin-conjugated secon-
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streptavidin. To determine the number of GFAP, AN2, and
Lex-SSEA-1 immunoreactive cells, photographs of immu-
nostained cells were taken using a high-resolution digital
camera (Zeiss AxioCam) under identical settings of
exposure and gain. The number of cells showing immuno-
reactivity was determined by counting between 100 and 200
cells per coverslip.
Immunohistochemistry
Embryos were collected as described before and trans-
ferred to ice-cold PBS. Embryonic brains were removed and
fixed in ice-cold 2% paraformaldehyde in PBS. The next
day, brains were washed in PBS and embedded in 3%
agarose in PBS. Coronal vibrotome sections were cut at a
thickness of 70–100 Am and then processed for immuno-
chemistry. Staining was revealed using Alexa 488 and PE-
conjugated secondary antibodies.Results
Isolation of NSCs expressing high levels of EGFR
To investigate the nature of late development neural
precursors expressing high EGFR levels, we isolated them
by flow cytometry. Since most antibodies specific for the
murine EGFR recognise intracellular epitopes, we used EGF
conjugated to Alexa 488 (EGF-A) as fluorescent label.
EGF-A retained the biological activity of EGF and could
replace it in inducing neurosphere formation. E18 striatal
cells, grown at clonal density in the presence of either EGF
or EGF-A, gave rise to similar number of neurospheresFig. 1. Detection of EGFRhigh cells using EGF conjugated to Alexa 488 (EGF-A). (
cells stained with EGF-A (FL1-H) and PI (FL2-H). The cell population analysed i
shown in R2 and R3, respectively. (B) Representative dot plots obtained after stain
left untreated (a). (C) EGF-A+ cells are not detected in FGF-2-treated E14-derive
prior to EGF-A labelling. FSC-H: forward scatter; SSC-H: side scatter; FL1-H an(1.83% T 0.17 and 2.45% T 0.65, respectively). Analysis of
EGF-A-labelled striatal cells by FACS reproduced the
profile of EGFR expression observed previously upon
immunostaining embryonic striatal cells with EGFR anti-
bodies (Fig. 1) (Ciccolini, 2001). In particular, we found
EGF-A+ cells in dissociated E18 but not E14 striatum (Fig.
1A, compare d to b). However, EGF-A+ cells were present
in cultures of E14 striatal cells that had been exposed for 24
h to FGF-2 (Fig. 1B, b). EGF-A+ cells were not observed if
striatal cells were exposed to EGF prior to staining with
EGF-A (Figs. 1C, a and b). Thus, EGF-A is not toxic, it
retains biological activity, and it competes with EGF for
receptor binding.
We next used clonal neurosphere assay to analyse the
self-renewal ability and the multipotency of sorted EGF-A+
cells (Reynolds and Weiss, 1996). EGF-A+ cells repre-
sented 1.6% of the gated cells (Table 1). When plated at
clonal density (1 cell/well) 1 in 4.25 T 0.78 EGF-A+ cells
gave rise to multipotent clones that could generate
secondary neurospheres and retained multipotentiality after
prolonged in vitro passaging (Table 1; Fig. 2). EGF-A
cells also gave rise to neurospheres albeit with a lower
frequency (1 in 214 T 41.1 cells). We next analysed
whether this difference in neural precursors frequency
between EGF-A and EGF-A+ cells was paralleled by a
differential expression of differentiation-specific markers.
Since, at E18, most of the cells are identified as Tuj1 or
Nestin immunoreactive (Ciccolini, 2001), we determined
the expression of these markers and of the antigen Ki67 in
the two cell populations. E18 striatal cells were stained
with EGF-A and sorted to separate EGF-A and EGF-A+
cells. Sorted cells were plated on PLL-coated chamber
slides, left to adhere in the incubator for 1 h, and then
processed for immunostaining. This analysis revealed that,A) Representative dot plots of dissociated E14 (a–b) and E18 (c–d) striatal
s shown in R1. Dead cells are shown in R4. EGF-A and EGF-A+ cells are
ing with EGF-A and PI E14 striatal cells exposed to FGF-2 for 24 h (b) or
d striatal cells (a) and E18 dissociated striatum (b) briefly exposed to EGF
d FL2-H: fluorescence levels 1 and 2.
Table 1
Neurosphere-forming cell (NFC) frequency is given by the ratio between
the number of neurospheres obtained after 10 days in vitro and the number
of cells initially plated at a density of either 10 (PI and PI EGF-A) or 1
(PI EGF-A+) cell per well
Population NFC frequency
E18 PI (92%) 1:60.4 T 8.9
PI EGF-A (84%) 1:214 T 46.1 (25.6%)
PI EGF-A+ (1.6%) 1:4.25 T 0.78 (24.3%)
E18 + 24 PI (80%) 1:76.05 T 22.9
PI EGF-A (74%) 1:740.9 T 259.1 (0.95%)
PI EGF-A+ (2.5%) 1:2.6 T 0.4 (91.4%)
E14 + 24 PI (84%) 1:43.5 T 2.1
PI EGF-A (75%) 1:175.3 T 32.1 (21.7%)
PI EGF-A+ (2%) 1:4.0 T 0.4 (25.9%)
E14 + 48 PI (82%) 1:51.8 T 13.5
PI EGF-A (71%) 0
PI EGF-A+ (5%) 1:4.2 T 0.4 (75.3%)
Values are the mean of three independent experiments. In column 2, values
in parentheses represent the number of cells found in each sorted population
as percentage of gated cells. In column 3, values in parentheses represent
the recovered stem cell activity as percentage of the stem cell activity found
in PI cell population.
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enriched in Nestin and Ki67-immunoreactive progenitors,
and depleted in Tuj1-expressing neurons (Fig. 2E). NSCs
but not more restricted precursors retain the ability to
generate neurons after prolonged culturing (Seaberg et al.,
2005). We then analysed whether clones derived fromFig. 2. E18 GZ contains EGFRlow and EGFRhigh multipotent precursors. (A–B) R
O4 immunopositive oligodendrocytes (A, green) or GFAP-immunoreactive astroc
single EGF-A+ cells. Hoechst staining of nuclei is shown in blue. (C) Western
different levels of EGFR protein (170 kDa). Protein loading and transfer were con
of TuJ1-immunoreactive neurons (red) and O4 immunopositive oligodendrocytes (
Quantitative analysis of E18 striatal EGF-A and EGF-A+ cells immunopositive f
independent experiments.sorted EGF-A+ gave rise to neurons after 10 passages. We
found that all clones analysed (n = 10) remained multi-
potent after long-term culturing (Fig. 2D). Thus, the
phenotypical characterisation shows that around 70% of
EGF-A+ cells are neural progenitors and clonal analysis
indicates that at least 20% of EGF-A+ cells display
properties of NSCs.
Since we had previously found that, at E18, most
precursors are EGF-responsive (Ciccolini, 2001), we next
investigated whether EGF-A cells divided and formed
neurospheres upon stimulation with EGF. Sorted E18 EGF-
A cells were plated in 96-well plates (10 cells/well) and
grown in the presence of EGF alone or in combination with
FGF-2. After 10 days, both growth factor regimes had
induced formation of neurospheres. Indeed, more clones
were found in cultures exposed to EGF alone (0.72% T
0.10) than to both EGF and FGF-2 (0.27% T 0.07). We then
directly measured levels of EGFR protein by Western blot in
sorted EGF-A and EGF-A+ cells. EGFR was expressed in
both cell populations; however, the expression of the
receptor was highly increased in EGF-A+ cells (Fig. 2C).
Taken together, these results indicate that EGF-A neuro-
sphere-forming cells display low EGFR levels rather than
lacking EGFR expression. Since EGF-A labelling reprodu-
ces the staining pattern previously obtained with EGFR
antibodies (Ciccolini, 2001), and separates two cell pop-
ulations displaying low and high levels of EGFR, hereafterepresentative examples of TuJ1-immunoreactive neurons (A and B, red) and
ytes (B, green) obtained after differentiation of neurospheres generated by
blot analysis of sorted E18 striatal EGF-A and EGF-A+ cells displaying
trolled by detection of alpha tubulin (55 kDa). (D) Representative examples
green) obtained after differentiation of long-term passaged neurospheres. (E)
or the indicated antigens. Data represent the means T SEM of at least three
Fig. 3. Development of EGFRhigh precursors. Representative sort profiles
obtained after EGF-A and PI staining of E18 EGFRlow cells that had been
previously purified by FACS and exposed to FGF-2 for 24 h (A) and of
cells derived from the adult SVZ (B). Dead cells are shown in R4. EGF-A
and EGF-A+ cells are shown in R2 and R3, respectively. FL1-H reveals
EGF-A; FL2-H reveals PI.
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and EGFRhigh, respectively.
To investigate whether EGFRhigh cells could also be
isolated from other regions of the embryonic brain, we next
used EGF-A to stain cells isolated from the neocortex.
Cortical tissue was dissected from E18 embryos and
dissociated cells were stained with EGF-A and analysed
by FACS. Similar to what we had previously observed with
striatal preparation, around 2% of the cortical cells stained
with EGF-A. Upon plating cortical EGFRhigh in 96-well
plates, as previously described for striatal EGFRhigh cells,
we found that neurosphere-generating precursors repre-
sented 17.6 T 2.99% of the plated cells (average of 6
independent experiments T SEM). In addition, neurospheres
derived from cortical EGFRhigh gave rise to both neuronal
and glial cells upon in vitro differentiation. Thus, at late
stages of development, EGFRhigh precursors with NSC
properties are also present in the neocortex.
EGFRhigh precursors in the developing telencephalon
EGF-responsive NSCs may arise during development
from FGF-2-responsive precursors (Ciccolini, 2001; Cicco-
lini and Svendsen, 1998) and it was conceivable that
EGFRhigh cells found at E14 after FGF-2 treatment (see
Fig. 1B, b) also contained NSC-like precursors. Therefore,
we next applied the same isolation procedure to FGF-2-
treated E14 striatal cells. As previously observed with E18-
derived cells, treatment for 24 h with FGF-2 induced the
appearance of an EGFRhigh cell population highly enriched
in neurosphere-forming activity (Table 1). Moreover, after a
48-h treatment with FGF-2, all neurosphere-forming cells
were in the EGF-A+ fraction (Table 1). However, in contrast
to their E18-derived counterpart, E14-derived EGFRlow
neurosphere-forming cells did not display a mitotic response
to EGF (clones obtained in EGF and FGF-2: 0.9% T 0.36;
clones obtained in EGF: 0.06% T 0.06). To further in-
vestigate the relationship between EGFRhigh and EGFRlow
cells, we next analysed whether also E18 EGFRlow cells
would overexpress EGFR after treatment with FGF-2.
Indeed, this was the case, and upon 24-h exposure to
FGF-2, almost all neurosphere-forming cells (91.4%) were
in the EGFRhigh population, with a frequency of 1 in 2.6 T
0.4 cells (Table 1). To directly prove that EGFRlow NSCs
give rise to EGFRhigh precursors, we sorted E18 EGFRlow
cells and plated them in the presence of exogenous FGF-2.
The next day, they were stained with EGF-A and analysed
by FACS. We found that a fraction of the total cell
population (0.95% T 0.15) was now EGFRhigh (Fig. 3A).
In addition, after sorting, these newly generated EGFRhigh
precursors gave rise to clonal neurospheres (data not
shown).
Next, we asked whether EGFRhigh cells could be isolated
from the adult CNS. Sections of adult brain containing the
SVZ were dissociated by mechanical trituration and
analysed by FACS after labelling with EGF-A. A small(around 0.24% of total cells) but distinct cell population was
EGFRhigh. In some experiments, the tissue derived from the
SVZ was enzymatically dissociated and cells were plated in
the presence of FGF-2. After a few hours, to re-establish
EGFR expression, cells were stained with EGF-A and sorted
by flow cytometry (Fig. 3B). When sorted EGFRlow and
EGFRhigh cells were grown in vitro to form neurospheres,
most neurosphere-forming activity segregated with the
EGFRhigh cell population, with 1 in 4.0 T 1.22 cells repre-
senting a neurosphere-forming cell.
Thus, the EGF-A isolation procedure in combination
with FGF-2 stimulation allows the recovering of the entire
population of neurosphere-forming cells from embryonic
and adult tissue.
Expression of differentiation-stage markers in EGFRhigh
precursors
To analyse the expression of relevant neural markers in
telencephalic EGFRhigh precursors, we stained dissociated
E18 striatal and cortical cells with EGF-A and isolated them
by flow cytometry. After sorting, cells were plated onto
PLL-coated chamber slides, and after 1 h, they were
processed for immunostaining. As illustrated in Table 2,
cortical and striatal E18 EGFRhigh precursors displayed a
similar antigenic pattern. The majority of EGFRhigh cells
expressed the neural gangliosides A2B5 (Eisenbarth et al.,
1979) and LB1 (Reynolds and Wilkin, 1988). Similar results
were obtained using flow cytometry to analyse E18 striatal
cells labelled with EGF-A and immunostained with A2B5
and LB1 antibodies (see supplementary data, Fig. 1 in
Appendix A). These experiments showed that the vast
majority of EGFRhigh precursors were A2B5+, LB1+ and
O4. Using immunocytochemistry, we also found that the
intermediate filament protein Nestin (Lendahl et al., 1990),
the radial glia markers RC2 (Misson et al., 1988), and brain
lipid binding protein (BLBP) (Feng and Heintz, 1995) were
similarly expressed by most EGFRhigh cells (Table 2).
Moreover, similar antigenic profiles were also displayed by
Table 2
Percentages of immunopositive cells in sorted E18 EGFRhigh cell
populations derived from the indicated brain region
Striatum Cortex SVZ
A2B5 93.6 T 6.3 89.8 T 1.8 ND
LB1 95.3 T 1.3 80.1 T 2.02 ND
Nestin 72.7 T 7.7 78.3 T 3.5 ND
RC2 69.5 T 3.5 68.6 T 6.35 ND
BLBP 75.0 T 6.8 83.0 T 4.9 ND
Lex-SSEA-1 5.0 T 0.4 ND 26.3 T 6.9
GFAP ND ND 40.0 T 1
AN2 32.4 T 8.4 ND 43.9 T 8.04
Values are the mean of at least three independent experiments T SEM. ND =
not determined; SVZ = subventricular zone.
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treatment with FGF-2 (data not shown).
We next analysed the expression of Lex/SSEA-1 (Solter
and Knowles, 1978), AN2 (Diers-Fenger et al., 2001), and
GFAP, that have been recently associated with multipotent
precursors in the adult SVZ (Capela and Temple, 2002;
Doetsch et al., 1999a; Aguirre et al., 2004) (Fig. 4 and Table
2). At E18, only around 5% of EGFRhigh cells was Lex/
SSEA-1-immunoreactive, 32% displayed weak immuno-
reactivity to AN2, and the majority did not express
appreciable levels of GFAP (Fig. 4). At E18, rare (less than
5%), strongly AN2 and GFAP-immunoreactive cells were
only found in the E18 EGFRlow population that also
displayed Lex/SSEA-1 and weak AN2 immunoreactivity
as the EGFRhigh counterpart (Fig. 4). However, GFAP and
Lex/SSEA-1 increased, both in terms of levels of expression
and of cell numbers, in SVZ-derived EGFRhigh precursors,
whereas we did not find a significant increase in AN2
immunoreactivity in adult EGFRhigh precursors (Fig. 4 and
Table 2). Thus, expression of GFAP and Lex/SSEA-1 in
EGFRhigh precursors increases with age.
We then investigated antigen expression in EGFRlow
neurosphere-forming cells. Since these cells could not be
directly identified and analysed, we took advantage of the
fact that both A2B5 and LB1 recognise extracellular
epitopes to sort immunopositive and immunonegative cells
and assess the respective neurosphere-forming abilities. We
reasoned that since we had previously found that virtually
all EGFRhigh precursors are also A2B5+ and LB1+ (see
supplementary data, Fig. 1 in Appendix A), eventual clones
generated from LB1 and A2B5 cells should derive from
EGFRlow cells. After dissection, cortical and striatal E18
cells were stained with A2B5 antibodies and sorted. Cortical
and striatal E18 cells displayed similar A2B5 immuno-
reactivity, with A2B5+ cells representing around 82% of the
viable cell population. In both brain regions, only A2B5+
cells gave rise to neurospheres. In the cortex, 1.5% T 0.05 of
A2B5+ cells gave rise to neurospheres, while in the striatum,
0.9% T 0.25 generated clones. No neurospheres were
obtained from either cortical or striatal A2B5 cells. We
made similar observations in cells stained with LB1
antibodies (data not shown). Thus, independent of EGFRlevels, most late development neurosphere-forming cells are
A2B5+ and LB1+.
Increase in EGFR levels is not coupled to a decrease in
neurogenic potential
Increase in EGFR signalling has been associated with a
restriction in neural precursor neurogenic potential (Bur-
rows et al., 1997). To investigate the ability of EGFRhigh to
generate neurons, we isolated by FACS EGFRhigh precur-
sors from dissociated E18 striatum or from E14 striatal cells
that had been previously exposed to FGF-2 for 24 h. We
then used the neurosphere assay to compare the ability of
E18 and E14-derived EGFRhigh precursors to generate
neurons under identical experimental conditions. We found
that, at both ages, the number of neurons generated by
single cells varied between 1 and more than 100 and that the
majority, but not all neurons, displayed a GABAergic
phenotype (Figs. 5A and B). Based on the number of
neurons generated in vitro, neural precursors were divided
into low (between 1 and 100 neurons) and highly neuro-
genic types (more than 100 neurons). Although both type of
clones were observed in either E18 or E14-derived
EGFRhigh precursors, their abundance varied between the
two age groups. At E18, only a fraction (around 4%) of
EGFRhigh precursors were highly neurogenic with the
majority being able to give rise to an average of 8 neurons
(Fig. 5C). A similar ability to generate neurons was
observed in EGFRhigh precursors isolated from E18 striatal
cultures that had been grown for 24 h in the presence of
FGF-2. In contrast, 40% of the E14-derived EGFRhigh
precursors gave rise to more than 100 neurons, with the
remaining cells being able to generate an average of 20
neurons each (Fig. 5C). At both ages, the increase in total
number of neurons was paralleled by an increase in the
percentages of neurons (Fig. 5C), indicating that the
changes in neuronal numbers reflected a change in differ-
entiation potential rather than cell generation ability. More-
over, the percentage of neurons generated decreased also
with age in both clone types (Fig. 5C) and these changes
were not connected to modifications in cell survival (data
not shown). Thus, despite increased EGFR levels, E14-
derived EGFRhigh precursors are more neurogenic than their
E18 counterpart. We next investigated the ability of
EGFRlow precursors to generate neurons and performed a
similar analysis on clonal neurospheres derived from
EGFRlow cells. At each age examined, EGFRlow cells gave
rise to low and high neurogenic clones with a frequency
similar to the one observed for EGFRhigh precursors of the
same age group (Fig. 5D). Indeed, EGFRlow cells contained
fewer highly neurogenic precursors than the EGFRhigh pool.
This difference is likely a consequence of the fact that, due
to the very low frequency of EGFRlow NSCs, we analysed
fewer clones derived from this cell population than from the
EGFRhigh subset. Thus, the number of highly neurogenic
clones and the neurogenic potential of each clone decline
Fig. 4. Expression of GFAP and Lex/SSEA-1 in EGFRhigh precursors increases with age. Representative examples of immunostaining of sorted cell populations
with antibodies to the indicated antigens. Ehigh = EGFRhigh Elow = EGFRlow; SVZ = adult subventricular zone. Scale bar is 20 Am.
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Fig. 5. Neurogenic potential of E14 and E18 stem cells. (A) Montage of fields showing TuJ1 immunopositive neurons generated from single E14-derived
EGFRhigh precursors. Images show representative examples of clones displaying high (a) and low (b) neurogenic potential. (B) Example of
immunofluorescence recorded from a differentiated neurosphere showing immunoreactivity to the indicated antigens. (C) Quantitative analysis of the
number of neurons in highly (>100) and low (1–100) neurogenic clones derived from single EGFRhigh isolated at the indicated ages. (D) Quantitative analysis
of the number of highly and low neurogenic clones derived from the indicated populations of sorted cells. Data represent the means T SEM of at least three
independent experiments.
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directly linked to EGFR levels.
EGFR signalling specifically modulates migration of
EGFRhigh cells
EGFR signalling may also regulate the migration of neural
cells. We next directly investigated whether EGFRhigh cells
displayed properties of migrating cells and whether their
movement was affected by EGFR signalling. After sorting,
E18 EGFRhigh and EGFRlow populations were labelled with
DiI and aggregates were prepared for both cellular subsets.
Cellular aggregates were positioned over the basal ganglia
region of E18 telencephalic slices that had been previously
exposed for at least 1 h to EGF, with or without the specific
EGFR blocker PD 158780, or left untreated as control. The
next day, slices were fixed and analysed. For both sets of
aggregates, we found that, in most cases, cells had migrated
from the cluster into the tissue (Fig. 6A). We next quantifiedfor each treatment the number of aggregates that displayed
migration and the distance of the migrating cells from the
cluster centre. As shown in Fig. 6B, in aggregates formed
from EGFRlow cells, both parameters were not affected by the
presence of EGF or EGF and PD 158780 in the culture
medium. In contrast, when aggregates of EGFRhigh cells were
analysed, we found that the ability of cells to migrate and
integrate into the telencephalic tissue was significantly
increased in the presence of EGF and was greatly reduced
by EGFR inhibition (Fig 6B). Thus, EGFRhigh precursors
display properties of migrating cells and their migration
ability is promoted by EGFR signalling. In contrast, the
movement of EGFRlow cells is not affected by EGFR activity.
EGFRhigh cells may represent tangentially migrating
precursors
Our data indicate that EGFR signalling modulates the
migration of EGFRhigh precursors. It has been shown that,
Fig. 6. EGFR signalling promotes migration of EGFRhigh precursors. (A) Fluorescent micrographs showing examples of cells migrating from aggregates of DiI-
labelled EGFRhigh (a, b) and EGFRlow (c) precursors that had been growing onto telencephalic slices for 24 h in the indicated conditions. Scale bar is 70 Am.
(B) Quantification of the number of aggregates displaying migrating cells (left panel) and of the distance of the migrating cells from the centre of the aggregate
(right panel) 24 h after being placed onto telencephalic slices in the indicated conditions. Data represent the means T SEM of three independent experiments.
‘Significantly different from control (P < 0.001). mSignificantly different from control (P < 0.5). *Significantly different from EGF (P < 0.01). E = EGF, PD =
PD158780.
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tangentially migrates from the striatal to the cortical GZ
(Anderson et al., 2001). These cells express the homeobox-
containing transcription factor Dlx-2 and may give rise to
Dlx-2 immunopositive precursors resident in the adult SVZ
that generates olfactory bulb interneurons throughout the
animal life. To investigate the relationship between
EGFRhigh precursors and tangentially migrating progeni-
tors, we first identified cells expressing high levels of
EGFR in brain sections. We used EGFR antibodies to stain
sections of E18 telencephalon. In stained sections, we
observed both radially and tangentially oriented EGFRhigh
cells (Fig. 7). Tangentially oriented cells were prevalent in
the cortex (Figs. 7f, g) and less abundant in the striatum
where columns of radially oriented cells were instead more
common (Fig. 7c). Radially orientated cells were present
especially in the VZ of the germinal epithelium (Figs. 7c,
g) while tangentially orientated cells were present mostly in
the SVZ as well as in the brain parenchyma (Figs. 7d, h).
The majority of radially oriented cells in the cortical
germinal zone were Nestin+ and Tuj1, whereas tangen-
tially oriented cells, both in the germinal epithelium and in
the parenchyma, expressed either Nestin or TuJ1 immuno-
reactivity (see supplementary data, Fig. 2 in Appendix A).
We next analysed co-expression of high EGFR levels and
neural antigens in acutely dissociated striatal cells. As
summarised in Table 3, we found that cells intensely stained
with EGFR antibodies expressed also RC2, Nestin, A2B5,and LB1 in proportions that were consistent with the results
that we had previously obtained with sorted EGFRhigh
precursors.
We next investigated whether sorted EGFRhigh precur-
sors expressed Dlx and Mash-1, two transcription factors
mainly found in cells originating from ventral regions of
the developing brain (Panganiban and Rubenstein, 2002;
Casarosa et al., 1999). Sorted cortical and striatal
EGFRhigh cells were allowed to attach to PLL-coated
chamber slides for 1 h and then processed for immuno-
staining using a pan Dlx antibody that recognise all
members of the Dlx family of transcription factors. In both
cell groups, the majority of the cells displayed Dlx
immunoreactivity (striatum 80%; cortex 60%) (Fig. 8A)
and most Dlx+ cells were also Nestin+ (see supplementary
data, Fig. 3 in Appendix A). In both groups, many cells
expressed also Mash-1 (Fig. 8A). Since GABAergic neu-
rons and oligodendrocytes are mainly generated from
precursors of the ventral GZ, we next analysed whether
single cortical EGFRhigh precursors could give rise to
GABAergic neurons in vitro. Indeed, we found that clones
derived from cortical EGFRhigh precursors contained both
cell types (Fig. 8B and data not shown). Thus, also
multipotent cortical EGFRhigh precursors display character-
istics of cells born in the ventral GZ.
Taken together, these results are consistent with the
hypothesis that EGFRhigh precursors represent a population
of precursors originating in the ventral region of the brain
Table 3
Percentages of dissociated striatal cells displaying immunoreactivity upon
staining with antibodies to indicated antigen alone (single) or in
Fig. 7. Identification of EGFRhigh cells in telencephalic sections.
Fluorescent micrographs showing representative examples of sections of
E14 (a, e) and E18 (b–d, f–h) striatum (a–d) and cortex (e–h) stained with
EGFR antibodies. Panels d and h illustrate high-power view of EGFRhigh
cells around the border between ventricular and subventricular zone. V
indicates the relative position of the ventricle. Arrows point at tangentially
oriented cells. Scale bar is 50 Am.
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development.combination with antibodies to EGFR (double)
Single Double
A2B5 78.7 T 3.5 2.1 T 0.3
LB1 64.3 T 8.9 5.4 T 2.17
Nestin 35.2 T 2.0 2.9 T 0.7
RC2 13.3 T 3.3 1.16 T 0.21
Values are the mean of three independent experiments T SEM.Discussion
In this study, we use a new isolation procedure to study
the development of multipotent precursors that express high
levels of EGFR.Few studies have so far described isolation of NSCs from
the mammalian CNS. Markers of the hematopoietic system
have been previously used to isolate NSCs from the human
embryonic brain (Uchida et al., 2000). However, with this
approach, it was possible to achieve a relatively low
enrichment in neurosphere-forming cells (1 in 23 cells).
Other groups have used negative selection to effectively
isolate adult (Rietze et al., 2001) or embryonic (Maric et al.,
2003) NSCs. However, since NSCs change their properties
during development, the effectiveness of this approach may
be limited to a restricted time frame. Yet, another strategy
has been the expression of fluorescent proteins under the
control of early neural promoters to target and isolate NSCs
(Keyoung et al., 2001). Here, we report a new, generally
applicable procedure for the isolation NSC-like precursors
across various embryonic ages and from different tissues.
This strategy is based on the observation that late develop-
ment neural precursors display increased levels of EGFR
expression and that a similar increase is promoted in
younger embryos by FGF-2 (Ciccolini and Svendsen,
1998; Ciccolini, 2001). We have here used a fluorescent
EGF conjugate (EGF-A) to monitor EGFR expression
providing several evidences that EGFR expression rather
than other mechanisms cause increase in EGF-A binding.
First, we found that EGF-A retains biological activity and
competes with EGF for a cell surface receptor. This is
consistent with previous findings showing that EGF
conjugates efficiently and specifically target EGFR and
are widely used for clinical applications such as in cancer
therapy (Lango et al., 2001). Secondly, to minimise the risk
that receptor/ligand turnover could affect our results, the
labelling with EGF-A was done at 4-C and cells were
analysed immediately after. Thirdly, the pattern of staining
obtained with EGF-A labelling and with antibodies against
intracellular portion of EGFR is identical (Ciccolini, 2001),
both revealing an intensely stained cellular subset in
dissociated cells derived from the E18 but not in the E14
striatum. Moreover, here, we show by Western blot analysis
a several-fold increase in EGFR levels of EGF-A+ cells
compared to the EGF-A population, demonstrating that
EGF-A labelling detects variations in EGFR levels. Our
interpretation is also consistent with the current view of the
mechanisms underlying EGFR/ligand interaction indicating
that receptor levels are a fundamental mechanism to
increase the number of high-affinity EGFR molecules
Fig. 8. EGFRhigh precursors display characteristics of cells originating from the ventral germinal zone. (A) Fluorescent micrographs illustrating representative
examples of sorted EGFRhigh precursors isolated from the shown brain regions of E18 embryos and stained with antibodies as indicated. (B) Examples of
GABAergic neurons obtained upon in vitro differentiation of neurospheres generated from isolated E18 cortical EGFRhigh precursors.
F. Ciccolini et al. / Developmental Biology 284 (2005) 112–125 123(Burgess et al., 2003). At E18, after dissection, and at E14,
upon exposure to FGF-2, neurosphere-forming cells were
found both in the EGF-A binding and not binding
populations, albeit at different frequencies. We also
observed that E18 cells that did not bind EGF-A were still
able to form clones when grown in the presence of EGF
alone, whereas their E14-derived counterpart did not. A
simple interpretation of this set of data is that, at both ages,
neurosphere-forming cells are heterogeneous with respect of
EGFR levels and that E14 EGFRlow cells express lower
amount of EGFR that their E18 complement. This inter-
pretation is consistent with previous analyses of EGFR
expression and function in developing neural precursors
(Ciccolini, 2001; Ciccolini and Svendsen, 1998). However,
a definite proof will require direct assessment of EGFR
levels in EGFRlow neurosphere-forming cells.
Our observation that EGFR levels increase in a subset of
late development precursors poses the question of the
biological meaning of this event. Previous evidence
suggests that EGF and FGF-2 elicit pleiotropic responses
and modulate proliferation or differentiation on neural
precursors depending on the intensity of the stimulation
(Burrows et al., 1997; Qian et al., 1997). Accordingly, it has
been suggested that the increase in EGFR levels observed
during development (Kornblum et al., 1997) not only
confers mitotic responsiveness to EGF but may also cause
a change in neural precursors differentiation potential
(Burrows et al., 1997). Here, we show that, at E18, EGF
is mitotic for both EGFRlow and EGFRhigh NSC-like
precursors, indicating that overexpression of EGFR is not
directly linked to acquisition of mitotic responsiveness to
EGF. We have also compared the differentiation potential of
EGFRhigh and EGFRlow precursors. We here find thatdevelopmental age and not EGFR levels directly affect
NSC neurogenic potential. An age-dependent decrease in
the number of neurons generated by isolated stem cells also
occurs in the case of cortical precursors (Qian et al., 2000).
Moreover, here, we provide evidence that such a reduction
in the number of generated neurons is due to a change in
stem cell potential rather than to a decrease in the number of
cells generated by a given precursor.
Our data indicate instead that changes in EGFR signal-
ling directly affect migration of EGFRhigh neural precursors.
In particular, we found that EGFR activity is required for the
migration of EGFRhigh precursors, while blockade of EGFR
signalling did not affect the migration of the majority of
EGFRlow cells. However, since, at E18, multipotent
EGFRlow cells did respond to EGF, we cannot exclude that
EGFR signalling may also affect their migration. This is
especially important in light of the fact that EGFR ligands
are expressed in the brain before EGFRhigh cells become
detectable (Assimacopoulos et al., 2003; Kornblum et al.,
1997). EGFR appears to modulate neural cell migration in
vitro and in vivo (Caric et al., 2001; Sibilia et al., 1998;
Threadgill et al., 1995). EGFR regulates migration also in
the context of adult brain. Infusion of EGF into the lateral
ventricle can change the direction of migration of adult SVZ
progenitors (Craig et al., 1996; Doetsch et al., 2002) and
infusion of transforming growth factor (TGF)-a, which
binds to EGFR, promotes an induction of precursor
proliferation and migration (Fallon et al., 2000). Previous
observations have suggested that EGFR signalling may
promote radial migration of cortical neural precursors from
the GZ (Caric et al., 2001). Here, we provide evidence that
at least some of the EGFRhigh precursors may represent
tangentially migrating cells. We showed that, independent of
F. Ciccolini et al. / Developmental Biology 284 (2005) 112–125124the region of isolation, several EGFRhigh precursors
displayed properties of cells originating in the ventral GZ,
such as expression of Dlx and Mash-1 transcription factors.
Most importantly, we found that clones derived from
cortical EGFRhigh cells contained GABAergic neurons and
oligodendrocytes. This strongly indicates that cortical
EGFRhigh cells contain not only differentiated progenitors
but also multipotent precursors that are derived from the
ventral GZ. Taken together, previous observations and our
data indicate that the increase in EGFR expression observed
in late development stem cells may underlie the departure of
this cell population from the GZ.Acknowledgments
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